LLL3

Research use only, not for human use.

LLL3 is a structural analogue of STA-21 that acts as a novel STAT3 inhibitor.

LLL3 is a structural analogue of STA-21 that acts as a novel STAT3 inhibitor, inhibits STAT3-dependent transcriptional and DNA binding activities; also inhibits viability of U87, U373, and U251 glioblastoma cells as well as induces apoptosis of these glioblastoma cell lines; exhibits prolonged survival in U87 glioblastoma tumour-bearing mice.

LLL 3

JAK/STAT Signaling

STAT

STAT

——

——

63972-38-3

266.25

C16H10O4

>98% (HPLC)

——

O=C(C1=C2C=CC=C1O)C3=CC=CC(C(C)=O)=C3C2=O

1-acetyl-5-hydroxyanthracene-9,10-dione

(-20℃)

With Ice Pack

≥ 2 years